58468-0040Level 3
Fabrazyme (AGALSIDASE BETA)
**Product type:** Human Prescription Drug
**Active ingredient:** AGALSIDASE BETA
**Strength:** 5 mg/mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** Genzyme Corporation
**Marketing category:** BLA (BLA103979)
**Pharmacologic class:** Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC], alpha-Glucosidases [CS]
GET
/api/v1/systems/ndc_fda/nodes/58468-0040Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.